Comorbidities impact a large proportion of patients with chronic obstructive pulmonary
disease (COPD), with over 80% of patients with COPD estimated to have at least one …

Despite anti-retroviral therapy (ART), human immunodeficiency virus-1 (HIV)-related
pulmonary disease continues to be a major cause of morbidity and mortality for people living …

Background: Previous uncontrolled reports have suggested that HIV-seropositive persons
develop an accelerated form of emphysema. Objective: To characterize the risk for …

Rationale: Before the introduction of combination antiretroviral (ARV) therapy, patients
infected with HIV had an increased prevalence of respiratory symptoms and lung function …

Factors modulating the variable progression of chronic obstructive pulmonary disease
(COPD) are largely unknown, but infectious agents may play a role. Because Pneumocystis …

Chronic obstructive pulmonary disease in women is an understudied subject but is gaining
attention as a significant public health threat. In developed countries, efforts at preventing …

Objective: As survival with HIV infection improves, HIV-infected individuals appear to be
susceptible to development of chronic diseases, including restrictive and obstructive lung …

The effectiveness of antiretroviral therapy to control HIV infection has led to the emergence
of an older HIV population who are at risk of chronic diseases. Through a comprehensive …

Smoking-related diseases, such as chronic obstructive pulmonary disease (COPD), are of
particular concern in the HIV-infected population. Smoking rates are high in this population …

Objectives: To determine the pattern and severity of impairment in pulmonary function in HIV-
infected compared with HIV-uninfected individuals. Methods: Cross-sectional analysis of …